Jaspal Taggar
Clinical Associate Professor in Primary Care & Head of Undergraduate Primary Care Education, Faculty of Medicine & Health Sciences
Contact
Biography
Having qualified as a GP in 2012, Dr Taggar works as salaried GP at a rural GMS practice. After leading the final year GP attachment for five years at the University of Nottingham, Dr Taggar was appointed as Head of Undergraduate Primary Care Education and Director of the Primary Care Education Unit. He enjoys combining his clinical role with research and teaching. Dr Taggar is passionate about developing and innovating Primary Care Education and combines this with aspirations of improving population health through research in atrial fibrillation, cardiovascular prevention and tobacco control. In addition to these roles, Dr Taggar is the National Institute for Health Research (NIHR) Clinical Research Network Lead for Primary Care (South) and is a regional panel member of the NIHR Research for Patient Benefit funding stream.
Qualifications:
MBChB, FRCGP, FRCP, PhD, MSc, AFHEA, DRCOG
Expertise Summary
- Cardiovascular prevention and atrial fibrillation
- Tobacco control
Teaching Summary
Dr Taggar provides leadership and strategic oversight of all taught courses in undergraduate primary care education. He teaches on the courses run by the Division of Primary Care across all years of… read more
Recent Publications
VAN DER WARDT, V., BURTON, J.K., CONROY, S., WELSH, T., LOGAN, P., TAGGAR, J., TANAJEWSKI, L. and GLADMAN, J., 2018. Withdrawal of antihypertensive therapy in people with dementia: feasibility study Pilot and Feasibility Studies. 4, 29 TAGGAR, J.S. and COLEMAN, T., 2016. Screening for atrial fibrillation in primary care: From recommendation to implementation European Journal of Preventive Cardiology. Published online before print: 2 June 2016, doi: 10.1177/2047487316652976 MACKENZIE, I.S., FORD, I., WALKER, A., HAWKEY, C., BEGG, A., AVERY, A., TAGGAR, J., WEI, L., STRUTHERS, A.D., MACDONALD, T.M. and ON BEHALF OF THE ALL-HEART STUDY GROUP, 2016. Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study BMJ Open. 6(9), e013774
Dr Taggar provides leadership and strategic oversight of all taught courses in undergraduate primary care education. He teaches on the courses run by the Division of Primary Care across all years of the medical curriculum involving topics such as ethics, communication and consultation skills and managing long-term conditions.
VAN DER WARDT, V., BURTON, J.K., CONROY, S., WELSH, T., LOGAN, P., TAGGAR, J., TANAJEWSKI, L. and GLADMAN, J., 2018. Withdrawal of antihypertensive therapy in people with dementia: feasibility study Pilot and Feasibility Studies. 4, 29 TAGGAR, J.S. and COLEMAN, T., 2016. Screening for atrial fibrillation in primary care: From recommendation to implementation European Journal of Preventive Cardiology. Published online before print: 2 June 2016, doi: 10.1177/2047487316652976 MACKENZIE, I.S., FORD, I., WALKER, A., HAWKEY, C., BEGG, A., AVERY, A., TAGGAR, J., WEI, L., STRUTHERS, A.D., MACDONALD, T.M. and ON BEHALF OF THE ALL-HEART STUDY GROUP, 2016. Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study BMJ Open. 6(9), e013774 TAGGAR, J. S., COLEMAN, T., LEWIS, S., HENEGHAN, C. and JONES, M., 2015. Accuracy of methods for diagnosing atrial fibrillation using 12-lead ECG: A systematic review and meta-analysis International Journal of Cardiology. 184, 175-183 TAGGAR, J., LEWIS, S., DOCHERTY, G., BAULD, L., MCEWEN, A. and COLEMAN, T., 2015. Do cravings predict smoking cessation in smokers calling a national quit line: secondary analyses from a randomised trial for the utility of 'urges to smoke' measures Substance Abuse Treatment, Prevention, and Policy. 10(1), 15 TAGGAR, J.S., COLEMAN, T., LEWIS, S., HENEGHAN, C. and JONES, M., 2015. Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: A systematic review and meta-analysis European Journal of Preventive Cardiology. First Published Online: 13 October 2015, doi: 10.1177/2047487315611347 HARRISON, J.K., VAN DER WARDT, V., GLADMAN, J., TAGGAR, J. and CONROY, S., 2015. Safe withdrawal of anti-hypertensive medication in older people with dementia: a review of the literature Journal of Human Hypertension. 29(10), 630 KWOK, T.C., TAGGAR, J., COOPER, S., LEWIS, S. and COLEMAN, T., 2014. Nicotine dependence and biochemical exposure measures in the second trimester of pregnancy. Nicotine and Tobacco Research. 16(2), 145-154 COOPER, S., TAGGAR, J., LEWIS, S., MARLOW, N., DICKINSON, A., WHITEMORE, R. and COLEMAN, T., 2014. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP trial The Lancet Respiratory Medicine. Early Online Publication: 11 August 2014, doi:10.1016/S2213-2600(14)70157-2 COOPER, S., LEWIS, S., THORNTON, J.G., MARLOW, N., WATTS, K., BRITTON, J., GRAINGE, M.J., TAGGAR, J., ESSEX, H., PARROTT, S., DICKINSON, A., WHITEMORE, R., COLEMAN, T. and FOR THE SMOKING, NICOTINE AND PREGNANCY (SNAP) TRIAL TEAM,, 2014. The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy; effectiveness and safety until 2 years after delivery, with economic evaluation Health Technology Assessment. 18(54), doi:10.3310/hta18540 COOPER, S., TAGGAR, J., LEWIS, S., MARLOW, N., DICKINSON, A., WHITEMORE, R. and COLEMAN, T., 2013. 2-year infant and maternal outcomes investigating nicotine-replacement therapy for smoking cessation in pregnancy from the SNAP trial: a randomised controlled trial The Lancet. 382, S7 TAGGAR, J.S. and HODSON, A., 2011. The assessment and management of palpitations in primary care. InnovAiT. 4, 408-413
FITZMAURICE, D.A., TAGGAR, J.S. and JOHNS, S.J., 2010. Atrial Fibrillation and Antithrombotic Therapy. RCGP News. 5, 6
JOHNS, S.J. and TAGGAR, J.S., 2010. Atrial Fibrillation. InnovAiT. 3, 578-586
TAGGAR, J.S., 2010. Audit of atrial fibrillation management at a district general hospital. British Journal of Cardiology. 17, 122
TAGGAR, J.S., 2009. Chapter 15: Angiotensin II receptor blockers and hypertension. In: LIP, G. and NADAR, S., eds., Hypertension Oxford University Press.
TAGGAR, J.S., WATSON, T., MUSARRAT, K. and MILLANE, T., 2009. Kounis syndrome presenting as ST-segment elevation myocardial infarction following a hymenoptera (bee) sting. International Journal of Cardiology. 136(2), e29-e30 TAGGAR, J.S. and LIP, G.Y.H., 2008. Idraparinux for the prevention of thromboembolism in patients with atrial fibrillation. Therapy Weekly. 5, 139-140
TAGGAR, J.S. and LIP, G.Y.H., 2008. Risk predictors for lone atrial fibrillation. Europace. 10(1), 6-8 TAGGAR, J.S. and LIP, G.Y.H., 2008. The QRISK was less likely to overestimate cardiovascular risk than the Framingham or ASSIGN equations. American College of Physicians Journal Club. 148, 25
TAGGAR, J.S., MARIN, F. and LIP, G.Y.H., 2008. Mortality in patients with atrial fibrillation: improving or not? Europace. 10, 389-390
TAGGAR, J.S. and CAREY, P.A., 2007. Adenosine challenge in the diagnosis of in-apparent accessory pathways. New Zealand Medical Journal. 120(1267), U2873
TAGGAR, J.S. and LIP, G.Y.H., 2007. Identifying atrial fibrillation in primary care. Mims Cardiovascular. 2, 18-20
BHALA, N. and TAGGAR, J., 2006. Clopidogrel and metoprolol in myocardial infarction. The Lancet. 367(9513), 812-813 TAGGAR, J.S. and LIP, G.Y.H., Atrial fibrillation: Current approaches to drug therapy. Prescriber. 19, 48-59